|
    MRNA U.S.: Nasdaq

    Moderna Inc.

    MRNAUS
    Premarket
    Last Updated: Oct 25, 2021 9:03 a.m. EDT Delayed quote

    $ 329.02

    2.48 0.76%
    Before Hours Volume: 81.19K
    Close Chg Chg %
    $326.54 -13.03 -3.84%
    Advanced Charting
    Volume: 7.78M 65 Day Avg: 16.2M
    48% vs Avg
    317.18 Day Range 335.75
    65.49 52 Week Range 497.49

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    MRNA Overview

    Performance

    5 Day
    • -2.48%
    1 Month
    • -20.13%
    3 Month
    • -2.78%
    YTD
    • 212.57%
    1 Year
    • 364.89%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 17 Full Ratings

    Recent News

    Moderna says its COVID-19 shot generates 'robust' response in children 6 to 11

    Moderna Says Interim Data Positive From Study of Covid-19 Vaccine in Children 6 to under 12

    Moderna plans to submit data to US FDA, EMA and other regulatory agencies

    Moderna says Phase 2/3 study of CoVID vaccine in kids aged 6 to 11 showed 'robust' antibody response after 2 50 mg doses

    Read full story

    Big Pension Sold GameStop Stock. It Bought Moderna and Ford Shares.

    Read full story

    Moderna Inc. stock falls Friday, underperforms market

    Read full story

    Pfizer data boosts hopes children will soon be eligible for COVID-19 vaccine, and CDC expands booster program

    Read full story

    Moderna Given Sell Rating at Deutsche Bank. The Stock Is Falling.

    Read full story

    Mix-and-Match Booster Rollout Is Set to Start. Nearly 100 Million People Could Be Eligible.

    Read full story

    People who got J&J’s COVID-19 shot can get a booster. Which one should they get?

    Read full story

    CDC approves expanded rollout of COVID-19 boosters

    Read full story

    CDC Advisors Unanimously Back Mixing Covid-19 Vaccine Boosters

    Read full story

    Moderna Inc. stock rises Thursday, outperforms market

    Read full story

    CDC gathers to discuss which patient groups should get Moderna and J&J COVID-19 vaccine boosters, and Pfizer reports positive results from booster trial

    Read full story

    Moderna Stock Is Rising After FDA Authorization of Mix-and-Match Boosters

    Read full story

    Tesla Just Had a Strong Quarter. Its Valuation Is for a Very Different Business.

    Read full story

    People Who Got Johnson & Johnson’s Covid-19 Shot Can Get a Booster. Which One Should They Get?

    Read full story

    FDA backs Moderna and J&J boosters, authorizes mixing COVID vaccines

    Read full story

    FDA Authorizes Mix-and-Match, J&J, and Moderna Boosters

    Read full story

    White House Lays Out Vaccine Rollout Plan for Kids Aged 5 to 11

    Does This News Make Johnson & Johnson a Buy?

    on Motley Fool

    Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

    on Zacks.com

    How Low Can Moderna Stock Go?

    on Motley Fool

    Could Moderna Stock Help You Retire a Millionaire?

    on Motley Fool

    Moderna Inc (MRNA) CEO Stephane Bancel Sold $6.4 million of Shares

    on GuruFocus.com

    Gateway Investment Advisers Llc Buys Moderna Inc, Occidental Petroleum Corp, Toll Brothers Inc, ...

    on GuruFocus.com

    Novavax Is Set to Win on the Increasing Necessity of Booster Shots

    on InvestorPlace.com

    Why Novavax Fell by 3% Today

    on Motley Fool

    Eaton Vance Worldwide Health Sciences Fund 2021 Annual Report

    on GuruFocus.com

    Top 5 Trades of the Eaton Vance Worldwide Health Sciences Fund

    on GuruFocus.com

    Why Moderna Stock Is Falling Today

    on Motley Fool

    Pfizer's (PFE) Comirnaty Booster Dose Achieves 95.6% Efficacy

    on Zacks.com

    Fastly, PagerDuty, Johnson & Johnson, Moderna and Pfizer highlighted as Zacks Bull and Bear of the Day

    on Zacks.com

    Friday’s Top Analyst Upgrades and Downgrades: Boeing, Freeport-McMoRan, Intel, Moderna, Nvidia, Southwest Air and More

    on 247WallSt.com

    What's the Outlook for Novavax Stock?

    on Motley Fool

    Moderna’s COVID-19 Vaccine Booster Dose Recommended by ACIP

    on TipRanks.com

    Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

    on Zacks.com

    Can Biotech ETFs Gain From Positive Booster Update?

    on Zacks.com

    Everence Capital Management Inc Buys Moderna Inc, Cisco Systems Inc, Lincoln National Corp, ...

    on GuruFocus.com

    Novavax (NVAX) Down on COVID Jab-Manufacturing Problem Reports

    on Zacks.com

    Moderna Inc.

    Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson 0.20% $430.99B
    Pfizer Inc. 0.70% $241.98B
    AstraZeneca PLC ADR 1.15% $191.93B
    AstraZeneca PLC 0.29% £139.36B
    GlaxoSmithKline PLC 0.37% £71.11B
    Gilead Sciences Inc. 0.37% $84.31B
    BioNTech SE ADR -2.80% $67.5B
    Regeneron Pharmaceuticals Inc. 0.53% $61.22B
    Biogen Inc. -2.00% $38.9B
    CureVac N.V. -3.98% $7.18B
    Competitor Data Provided ByCapital Cube Logo